What the $750m Eli Lilly and Resilience investment means for medicine supply
Eli Lilly and Resilience are investing $750 million to expand U.S. KwikPen production in Ohio. See why manufacturing execution now matters.
Pharma & Biotech
Medical Devices & Diagnostics
Why the Ro and Eli Lilly KwikPen move matters for obesity drug access, adherence, and pricing
Ro launches Eli Lilly’s Zepbound KwikPen nationwide. Read what this means for GLP-1 access, pricing, adherence, and obesity care models.